… failure in COVID-19 infected patients with interstitial pneumonia. This study will also provide
… A phase two multi-center randomised controlled trial (RCT) with two parallel arms (1:1 ratio). …

… with improved survival among COVID-19 patients. Our … a foundational treatment for
hospitalized COVID-19 patients. … study conducted using data from a phase 3, randomized trial …

… in the treatment of hospitalized patients with COVID-19. The goals of the present study were
to … Results of a recently published large multi-center observational cohort study showed that …

… articles on phase III randomized clinical trials and meta-analyses regarding the use of
sarilumab in the treatment of severe COVID-19. We searched using the terms “COVID-19”, “SARS-…

… retrospective, multi-center study, we extracted the clinical data on 416 cases of COVID-19
with … characteristics and treatment regimens. Outcomes were followed up until Feb 17, 2020. …

… Our meta-analysis mainly focused on the efficacy of corticosteroid therapy on COVID-19
patients. We searched electronic databases including PubMed, Web of Science, Embase, and …

… The purpose of this study is to test the safety and effectiveness of individually … care on blood
oxygenation and systemic cytokine release syndrome in patients with COVID-19 coronavirus …

… trials, here we report our experience with tocilizumab in patients with severe COVID-19. … In
conclusion, tocilizumab shows promise in the treatment of severe COVID-19. Tocilizumab may …

… We identified 50 ongoing RCTs related to antithrombotic therapy in hospitalized non-ICU
patients with COVID-19. Most trials (44 of 50) are open-label. The antithrombotic agents under …

… We only included RCTs in this NMA because non-randomized trials and observational
studies were considered of low certainty from the causal inference perspective (14). We included …